CoChat

GVS‐111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons

Pelsman, Alejandra, Hoyo‐Vadillo, Carlos, Gudasheva, Tatiana A., Seredenin, Sergei B., Ostrovskaya, Rita U., Busciglio, Jorge · 2003 · International Journal of Developmental Neuroscience
Cited by 65

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The neuroprotective activity of a novel N‐acylprolyl‐containing dipeptide analog of the nootropic 2‐oxo‐1‐pyrrolidine acetamide (Piracetam) designated as GVS‐111 (DVD‐111/Noopept) was tested in two in vitro models of neuronal degeneration mediated by oxidative stress: normal human cortical neurons treated with H 2 O 2, and Down's syndrome (DS) cortical neurons. Incubation of normal cortical neurons with 50 μM H 2 O 2 for 1 h resulted in morphological and structural changes consistent with neuronal apoptosis and in the degeneration of more than 60% of the neurons present in the culture. GVS‐111 significantly increased neuronal survival after H 2 O 2‐treatment displaying a dose‐dependent neuroprotective activity from 10 nM to 100 μM, and an IC 50 value of 1.21±0.07 μM. GVS‐111 inhibited the accumulation of intracellular free radicals and lipid peroxidation damage in neurons treated with H 2 O 2 or FeSO 4, suggesting an antioxidant mechanism of action. GVS‐111 exhibited significantly higher neuroprotection compared to the standard cognition enhancer Piracetam, or to the antioxidants Vitamin E, propyl gallate and N‐tert‐butyl‐2‐sulpho‐phenylnitrone (s‐PBN). In DS cortical cultures, chronic treatment with GVS‐111 significantly reduced the appearance of degenerative changes and enhanced neuronal survival. The results suggest that the neuroprotective effect of GVS‐111 against oxidative damage and its potential nootropic activity may present a valuable therapeutic combination for the treatment of mental retardation and chronic neurodegenerative disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0736-5748(03)00031-5

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 65

Metadata

Authors
Pelsman, A., Hoyo‐Vadillo, C., Gudasheva, T. A., Seredenin, S. B., Ostrovskaya, R. U., & Busciglio, J.
Venue
International Journal of Developmental Neuroscience
Publisher
Wiley
Published
2003-04-11
Volume
21
Issue
3
Pages
117-124
ISSN
  • 0736-5748 (ISSN-L)
  • 1873-474X
OpenAlex
W2024491864
Cited by
65
References
5
FWCI
2.38
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GVS‐111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. https://app.cochat.ai/papers/10.1016/s0736-5748(03)00031-5
The paper
Pelsman, A., Hoyo‐Vadillo, C., Gudasheva, T. A., Seredenin, S. B., Ostrovskaya, R. U., & Busciglio, J. (2003). GVS‐111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. International Journal of Developmental Neuroscience. https://doi.org/10.1016/s0736-5748(03)00031-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.